Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating perennial allergic rhinitis

A perennial technology for allergic rhinitis, applied in the direction of drug combination, pharmaceutical formula, allergic diseases, etc., can solve the problem that women are prone to menstrual disorders, uterine blood, endocrine disorders, acne or sexual dysfunction, affecting work and other problems. Learning and other issues to achieve the effect of anti-allergic reaction, fast effect, and avoid affecting physical health

Inactive Publication Date: 2002-07-10
曾咏梅
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, new oral antihistamine and antiallergic drugs are widely used clinically, such as terfenadine, clementine, centrum, totifen, sodium chromylate, dunk, rifutin, etc. It can control the clinical symptoms, but the maintenance time is short, and long-term medication affects the health. For example, the subjective symptoms can disappear after Dunke is injected into the human body, but it is easy to cause menstrual disorders, uterine blood, and endocrine disorders in women, and local acne or sexual dysfunction in men. Wait
Other drugs have different degrees of drowsiness symptoms, affecting work and study
And no relevant patents were found after searching

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Embodiment 1: adopt the raw material of following ratio to make medicament:

[0024] Sodium chromylate 90mg Chlorpheniramine 30mg

[0025] Prednisolone 110mg 2% Furanesin Solution 100ml

Embodiment 2

[0026] Embodiment 2: adopt the raw material of following ratio to make medicament:

[0027] Sodium chromylate 100mg Chlorpheniramine 40mg

[0028] Prednisolone 125mg 2% Furanesin Solution 100ml

Embodiment 3

[0029] Embodiment 3: adopt the raw material of following ratio to make medicament:

[0030] Sodium chromylate 110mg Chlorpheniramine 50mg

[0031] Prednisolone 135mg 2% Furanesin Solution 100ml

[0032] With 100 cases of patients clinical trials, its use effect is shown in Table 2:

[0033] Table 2

[0034] Gained from Table 2, the therapeutic effect of embodiment 2 is the best, is the best proportioning of the present invention.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention is one kind of medicine for treating perennial allergic rhinitis. Oral antiallergic medicine chromoglycate sodium, chlorphenamine and Prednisolone acetate and externally used rhinitis treating medicine Fuma liquid are compounded in certain proportion to prepare the medicine for treating allergic rhinitis through local application. The medicine can resist allergic reaction, inhibit excitation of sympathetic nerve, reduce the reaction of nasal mucous membrane to histamine, reduce the pathological reaction of nasal mucous membrane to various irritative damage, inhibit proliferation and exudation of connective tissue and relieve various rhinitis symptoms. It has obvious treating effects and no negative reaction.

Description

1. Technical field [0001] The invention relates to a medicine for treating rhinitis, in particular to a medicine for treating perennial allergic rhinitis. 2. Background technology [0002] Perennial allergic rhinitis is a common and frequently-occurring disease in the Department of Otorhinolaryngology. Due to air pollution and climate change, the patient suffers from repeated attacks. Its incidence rate accounts for about 15%-20% of the population. According to epidemiological investigations, about 10% of patients may be complicated by bronchial asthma. Due to the increasing number of antigens and allergens and the uncontrollable various environmental factors, its onset The rate has an increasing trend. Its clinical manifestations are characterized by stubborn nasal obstruction, nasal itching, sneezing, and watery mucus, which is very painful. Due to the secretion of glands in the nasal mucosa and the expansion of blood vessels, it is mainly regulated by parasympathetic ne...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/57A61P11/02A61P37/08
Inventor 曾咏梅
Owner 曾咏梅
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com